Anzeige
Mehr »
Login
Samstag, 18.09.2021 Börsentäglich über 12.000 News von 674 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AN1Z ISIN: SE0000767188 Ticker-Symbol: 7AL 
Stuttgart
17.09.21
10:30 Uhr
0,405 Euro
-0,027
-6,15 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ALLIGATOR BIOSCIENCE AB Chart 1 Jahr
5-Tage-Chart
ALLIGATOR BIOSCIENCE AB 5-Tage-Chart

Aktuelle News zur ALLIGATOR BIOSCIENCE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ALLIGATOR BIOSCIENCE Aktie jetzt für 0€ handeln
10.09.Positive outcome for Alligator Bioscience's joint study with Scandion Oncology1
02.09.Alligator Bioscience: Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline145LUND, Sweden, Sept. 2, 2021 /PRNewswire/ -- Alligator Bioscience AB ("Alligator" or the "Company") today announces that the Company, in order to enable further progress, will begin evaluating...
► Artikel lesen
02.09.Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination Therapy175STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Alligator Bioscience AB (Nasdaq Stockholm: ATORX) and Scandion Oncology A/S (Nasdaq Stockholm: SCOL), today announced the conclusion of their...
► Artikel lesen
02.09.Positive Results from the Scandion Oncology A/S and Alligator Bioscience AB Collaboration Further Supports Efficacy of SCO-101 in Combination Therapy3
19.08.Alligator Bioscience enters collaboration with Orion Corporation3
18.08.Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation309STOCKHOLM, Aug. 18, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company has entered into a research collaboration and license agreement with...
► Artikel lesen
18.08.Orion Oyj: Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration and license agreement430ORION CORPORATION PRESS RELEASE 18 AUGUST 2021 at 9.00 a.m. EEST Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration and license agreementOrion Corporation...
► Artikel lesen
16.08.Alligator Bioscience Announces New Senior Director of Communications & Investor Relations146LUND, Sweden, Aug. 16, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that Julie Silber has joined the company as the new Senior Director of Communications...
► Artikel lesen
13.07.Alligator Bioscience reports Q2 results1
13.07.Key advancements for Alligator Bioscience in Q21
13.07.Alligator Bioscience AB: Interim report January-June 2021197STOCKHOLM, July 13, 2021 /PRNewswire/ -- Positive Phase I data for ATOR-1017 "As new CEO of Alligator Bioscience, after just around a month, let me say that my high expectations on the...
► Artikel lesen
30.06.Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data249LUND, Sweden, June 30, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) and Scandion Oncology (Nasdaq Stockholm: SCOL) today announces promising preclinical data from their...
► Artikel lesen
04.06.Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017215LUND, Sweden, June 4, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today presents novel supportive data from the ongoing Phase I clinical trial with the 4-1BB (CD137)...
► Artikel lesen
01.06.Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021225LUND, Sweden, June 1, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the annual general meeting was held in the company this day. In light of the...
► Artikel lesen
04.05.Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field267LUND, Sweden, May 4, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research agreement with BioArctic AB, a Swedish research-based...
► Artikel lesen
30.04.Board member in Alligator Bioscience resigns at his own request1
27.04.Alligator Bioscience AB: Interim report January-March 2021229STOCKHOLM, April 27, 2021 /PRNewswire/ -- High activity during the first quarter "So...
► Artikel lesen
26.04.Notice of annual general meeting in Alligator Bioscience AB-
22.04.The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB344STOCKHOLM, April 22, 2021 /PRNewswire/ -- Ahead of the annual general meeting in Alligator Bioscience AB on June 1, 2021, the Nomination Committee announces its proposals regarding Chairman...
► Artikel lesen
15.04.MacroGenics teams up with Alligator Bio to develop novel immunotherapy2
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1